This is a very important idea, not only for understanding the pathogenesis of AD, but also for developing therapeutic strategies, because drugs targeted to Aβ are unlikely to be effective on tau aggregation and related neurodegeneration if Aβ are simply secreted from cells with tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.